Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.980
+0.097 (10.94%)
At close: Nov 20, 2024, 4:00 PM
0.950
-0.030 (-3.06%)
After-hours: Nov 20, 2024, 4:09 PM EST
Opus Genetics Employees
Opus Genetics had 14 employees as of December 31, 2023. The number of employees increased by 5 or 55.56% compared to the previous year.
Employees
14
Change (1Y)
5
Growth (1Y)
55.56%
Revenue / Employee
$598,643
Profits / Employee
-$1,942,286
Market Cap
30.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HOOKIPA Pharma | 179 |
| Precision Optics Corporation | 84 |
| SAB Biotherapeutics | 57 |
| Curis | 49 |
| Apollomics | 45 |
| Elevation Oncology | 29 |
| Iterum Therapeutics | 14 |
IRD News
- 8 days ago - Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire